display ongoing
results: demonstrated suggested inconclusive safety concern ongoing study
breast cancer - adjuvantbreast cancer - HR positive
breast cancer - adjuvantla/mBC - HR positivela/mBC - HR-positive - 1st line (L1)
palbociclib plus endocrine therapy PENELOPE-B KCSG-BR15-10 PENELOPE-B

Study type:

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons